Precision medicine is being propelled by biotechnology developments, data collected through personal devices and diagnostic tools, individualized solutions shaped by advanced analytic engines, and the digitization of health records.
Join our panel event as we explore recent advances in precision medicine, how digital devices and EHR data are contributing to the evolution of predictive algorithms in personalized medicine, and how business models can incentivize continued growth in this evolving market.
Celine Pallaud, VP & Global Head of Biomarkers & Diagnostics at Novartis
Dmitry Korkin, Director of Bioinformatics & Computational Biology Program & Professor of Computer Science at WPI
Moderated by: Craig Steger, SVP Outcome Capital, Healthcare & Life Science Investment Banking